Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

YOUR TASKS AND RESPONSIBILITIES   The primary responsibilities of this role, Executive Director US Medical Affairs Specialized Therapeutics MD, are to:    Participate and interact effectively with Global teams to ensure appropriate US direction of the company’s research and marketing efforts relative to the US environment; Be responsible for the design, planning and execution of an overall medical strategy including creating, organizing and leading Advisory Boards; Provide support and medical ex...

YOUR TASKS AND RESPONSIBILITIES   The primary responsibilities of this role, Director Global Forecasting, are to:      Act as a business advisor to Therapeutic Area (TA) Head, Strategic Marketing Leadership team to ensure a robust epi-based fifteen (15) year forecast architecture is established for VITRAKVI & the TKI Brands (Stivarga & Nexavar) Lead the production and interpretation of data and models for global brand team forecasts and standard reports (e.g. weekly Key Performance Indic...

YOUR TASKS AND RESPONSIBILITIES   The primary responsibilities of this role, Quality Assurance Specialist, are to:    Plan and conduct routine in-progress inspections, testing facility inspections (internal and external), data audits, and phase, interim, summary and final reports independently; Prepare inspection/audit reports of an analytical and interpretive nature; Write and review Standard Operating Procedures; Review corrective action reports for appropriateness, completeness and compliance...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Zakres obowiązków: Realizacja założonego planu sprzedaży w regionie, Promowanie produktów firmy Bayer z obszaru kardiologii, Reprezentowanie firmy w kontaktach z lekarzami specjalistami, m.in. kardiologami, chirurgami oraz lekarzami POZ Utrzymywanie i rozwijanie kontaktów ze środowiskiem medycznym Wymagania: Wykształcenie wyższe (medyczne, biologiczne lub pokrewne mile widziane), Poparte dowodami doświadczenie w pracy na podobnym stanowisku min. 2 lata Znajomość środowiska medycznego w obszarze ...

GET TO KNOW OUR AREA:   Bayer, a company focused on offering science for a better life, knows where treatment begins with an early and accurate diagnosis. Health professionals have the ability to provide clear direction in times of uncertainty in a patient's clinical course. And that is why, for more than 100 years, Bayer has been offering a range of products and services that support each health professional in their best decision-making. Bayer Radiology would be no different. The search fo...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

Bayer’s Cardiorenal division is undergoing an impressive growth trajectory and significant R&D investment.  Bayer is committed to improving cardiorenal health both in the US and globally with currently available products and products in development, including investigational treatments for Chronic Kidney Disease (CKD), heart failure with reduced and preserved ejection fraction, and renal anemia.  Given the profound burden of CKD in Type 2 Diabetes (T2D), Bayer is making significant investmen...

The HSE Advisor l eads the Singapore HSE function; responsible for meeting national and local regulations for Occupational Health, Safety and the Environment as well as the Global and Regional HSE standards and policies. Supporting Singapore office locations (2), R&D sites (2) and field-based staff (PH/CH/CS). Works closely with the ASEAN HSE Team to implement the sub-regional HSE strategy. S upport the development and implementation of HSE systems and initiatives across ASEAN, with a focus ...